# Bioinformatic analysis of the potential common pathogenic mechanisms for gastric precancerous lesions and Helicobacter pylori

**Authors:** Liufeng Yi, Tiantong Jiang, Siyu Tao, Nachuan Li, Yuan Ding, Meng Li, Shaoli Wang, Zhen Liu

PMC · DOI: 10.3389/fgstr.2025.1598916 · Frontiers in Gastroenterology · 2025-10-07

## TL;DR

This study uses bioinformatics to find shared genes and pathways between gastric precancerous lesions and Helicobacter pylori, highlighting immune and chemokine mechanisms.

## Contribution

Identifies seven hub genes and immune-related pathways linking gastric precancerous lesions and H. pylori.

## Key findings

- 189 differentially expressed genes were identified between gastric precancerous lesions and H. pylori.
- Seven hub genes (IL6, FCGR3A, CCL3, CXCR4, CXCL9, CCL4, CCR1) showed high diagnostic potential.
- Immune system and chemokine signaling pathways were found to be central to the disease progression.

## Abstract

Gastric precancerous lesions (GPL) represent a critical stage in the progression from gastritis to gastric cancer (GC). Helicobacter pylori (H. pylori) infection is a significant etiological factor exacerbating the inflammatory-cancerous transformation. The host immune status is a central regulatory mechanism for GPL, while persistent H. pylori infection drives changes in the immune microenvironment (IME). However, the potential pathological link between GPL and H. pylori remains unclear. This study aims to identify common differentially expressed genes (DEGs) between GPL and H. pylori using bioinformatics analysis, thereby elucidating their shared pathogenic mechanisms.

DEGs were extracted from GPL datasets (GSE87666) and H. pylori datasets (GSE60427) sourced from the Gene Expression Omnibus (GEO) database through GEO2R and R software. Protein-protein interaction (PPI) networks were generated using the STRING database and analyzed with Cytoscape software to identify hub genes. The diagnostic value of these hub genes was evaluated through Receiver Operating Characteristic (ROC) curves and Area Under the Curve (AUC) analysis, validated with datasets GSE130823, GSE60662, and GSE5081. Immune infiltration analysis of key genes was conducted using the CIBERSORT algorithm and ssGSEA. Gene mutation analysis was carried out using the cBioPortal database, and small molecule drugs were detected using the Connectivity Map (CMap) database.

The analysis revealed 189 DEGs. Functional enrichment analysis highlighted pathways related to immune system regulation, leukocyte migration and chemotaxis, cytokine-cytokine receptor interaction, and chemokine signaling. Seven hub genes were identified: IL6, FCGR3A, CCL3, CXCR4, CXCL9, CCL4, and CCR1. High AUC values for these hub genes indicated their potential for predicting disease occurrence.

This research identified seven hub genes closely related to GPL and H. pylori, elucidating potential mechanisms of disease progression, particularly emphasizing the roles of the IME and chemokine activity. These findings may provide insights for identifying disease biomarkers, inhibiting the “inflammation-cancer” transformation, and preventing GC. Furthermore, the targets and molecular mechanisms identified in this study require further experimental validation to confirm their therapeutic potential.

## Linked entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569], FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214], CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348], CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852], CXCL9 (C-X-C motif chemokine ligand 9) [NCBI Gene 4283], CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351], CCR1 (C-C motif chemokine receptor 1) [NCBI Gene 1230]
- **Diseases:** gastric cancer (MONDO:0001056), gastritis (MONDO:0004966)
- **Species:** Helicobacter pylori (taxon 210)

## Full-text entities

- **Genes:** FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CCR1 (C-C motif chemokine receptor 1) [NCBI Gene 1230] {aka CD191, CKR-1, CKR1, CMKBR1, HM145, MIP1aR}, CXCL9 (C-X-C motif chemokine ligand 9) [NCBI Gene 4283] {aka CMK, Humig, MIG, SCYB9, crg-10}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}
- **Diseases:** cancer (MESH:D009369), inflammation (MESH:D007249), H. pylori infection (MESH:D016481), GPL (MESH:D011230), gastritis (MESH:D005756), GC (MESH:D013274)
- **Species:** Helicobacter pylori (species) [taxon 210]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12952389/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12952389/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12952389/full.md

---
Source: https://tomesphere.com/paper/PMC12952389